Wednesday, August 12, 2026

CBP AMO emphasizes operational strength and values in early July Twitter posts

CBP AMO posted a series of tweets from July 5-7, 2026 highlighting their equipment capabilities and organizational values.
X / Twitter
LinkedIn
Print

CBP AMO, the Air and Marine Operations division of U.S. Customs and Border Protection, shared a series of posts on its official Twitter account between July 5 and July 7, 2026. The tweets highlighted themes of operational capability, motivation, and core values.

On July 5, CBP AMO posted: “Nothing screams freedom like 1400 horsepower! https://t.co/OTQwe2QWfd”. The following day, the agency tweeted: “Boots on the ground, eyes in the sky! #MondayMotivation https://t.co/A897deNUIN” on July 6. On July 7, CBP AMO shared another message emphasizing its guiding principles: “HONOR
COURAGE
COMMITMENT
#ProtectingAmerica https://t.co/I0iOww9TX7″
.

CBP AMO is responsible for providing air and maritime law enforcement support to safeguard America’s borders. As part of U.S. Customs and Border Protection, it operates a fleet of aircraft and vessels designed for border security missions across land, sea, and airspaces. The division’s public messaging often highlights its operational readiness and commitment to national security.

Filed Under

Share This Story

X / Twitter
LinkedIn
Email
Print

Advertisement

300 × 250

Related

Daily Dispatch

The morning briefing on federal government — delivered to your inbox before 7 AM.

Advertisement

300 × 120

More from Defense

Washington National Guard Continues Statewide Wildfire Response

The Washington National Guard continued deploying air and ground assets across the state on Aug. 10 as multiple wildfires burned simultaneously in the Pacific Northwest. Federal active-duty forces from Joint...

OCC Signals Push to Revive New Bank Charter Applications

The Office of the Comptroller of the Currency announced on Aug. 11 that it will prioritize new bank charter applications as part of a “community bank comeback” initiative. The effort...

FDA Approves First Oral PCSK9 Inhibitor to Lower Cholesterol

The FDA approved the first oral PCSK9 inhibitor for lowering LDL cholesterol in adults on July 17, removing a major barrier to broader use of the most powerful class of...